Oscar Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2023 Annual Meeting of Stockholders held on June 8, 2023. The filing covers the voting outcomes for director elections, auditor ratification, and executive compensation advisory votes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
As of the record date (April 13, 2023), there were 885,508,089 total votes available. A quorum was established with 785,691,745 votes represented. All three proposals were approved:
- Item 1 (Director Election): All ten nominees were elected. Notable vote counts included Mark T. Bertolini (753,365,522 FOR) and Joshua Kushner (724,585,176 FOR).
- Item 2 (Auditor Ratification): PricewaterhouseCoopers LLP was ratified with 784,934,535 votes FOR and 691,172 votes AGAINST.
- Item 3 (Executive Compensation): The advisory vote on named executive officer compensation passed with 752,930,211 votes FOR and 667,799 votes AGAINST.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the dual-class voting structure: Class B shares carry 20 votes per share, significantly influencing the outcome of the director election.
- Confirm the specific terms of the newly elected directors' tenure, which extends until the 2024 Annual Meeting.
- Review the Definitive Proxy Statement filed on April 27, 2023, for detailed biographies of the elected directors and the rationale behind the executive compensation plan.